Lagura, Blaze .

HRN: 27-35-41  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CEFUROXIME 750MG (VIAL)
06/23/2025
06/30/2025
IV
350mg
Q8
Acute Bacterial Infection
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines